WCN25-2364 COMPARISON OF ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN (R-ATLG) VS. ANTI-THYMOCYTE GLOBULIN (R-ATG) AS AN INDUCTION AGENT IN KIDNEY TRANSPLANTATION: A 5-YEAR RETROSPECTIVE SINGLE CENTER OBSERVATIONAL STUDY

WCN25-2364 COMPARISON OF ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN (R-ATLG) VS. ANTI-THYMOCYTE GLOBULIN (R-ATG) AS AN INDUCTION AGENT IN KIDNEY TRANSPLANTATION: A 5-YEAR RETROSPECTIVE SINGLE CENTER OBSERVATIONAL STUDY

Saved in:

Bibliographic Details
Main Authors:	Vijay Sinha, Amit Devra, Ravi SIngh
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924029334
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4410 COMPARATIVE EFFICACY OF ANTI-THYMOCYTE GLOBULIN (ATG) VS. ANTI-T-LYMPHOCYTE GLOBULIN (ATLG) IN ABO INCOMPATIBLE RENAL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE
by: Dr Ashwani Gupta, et al.
Published: (2025-02-01)

WCN25-2412 COMBINED INDUCTION THERAPY WITH RABBIT ANTI-THYMOCYTE GLOBULIN (rATG) AND RITUXIMAB IN COMPARISON WITH rATG ALONE ON RENAL ALLOGRAFT OUTCOMES IN NON-SENSITIZED LIVE RECIPIENTS
by: Praveen G, et al.
Published: (2025-02-01)

WCN25-3854 USE OF GRAFALON (R-ATLG) AND THYMOGLOBULIN (R-ATG) AS INDUCTION IN ABO-INCOMPATIBLE TRANSPLANT RECIPIENTS WITH ANTI-HLA SENSITIZATION
by: Rajkumar Sharma, et al.
Published: (2025-02-01)

WCN24-2364 COMPARING HORSE VS RABBIT ATG AS INDUCTION THERAPY IN KIDNEY TRANSPLANT
by: PAVANKUMARRAO NAVVA, et al.
Published: (2024-04-01)

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes
by: Simon Bond, et al.
Published: (2021-12-01)

Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review.
by: Rahul Mittal, et al.
Published: (2025-01-01)

Impact of Organ Donor Pretreatment With Anti-Thymocyte Globulin in a Murine Model of Allogenic Kidney Transplantation
by: An He, et al.
Published: (2025-01-01)

Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better
by: Lan Zhu, et al.
Published: (2025-01-01)

Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications
by: Haitao Wang, et al.
Published: (2025-08-01)

WCN24-1013 OUTCOMES WITH USE OF ANTI-THYMOCYTE GLOBULIN FOR TREATMENT OF ACUTE TCMR IN STANDARD RISK KIDNEY TRANSPLANTATION
by: R.A.B.E.E.A. AZMAT, et al.
Published: (2024-04-01)

Case Report: Successful treatment of steroid- and ruxolitinib-refractory gastrointestinal acute graft-versus-Host disease with anti-thymocyte globulin
by: Lulu Zhang, et al.
Published: (2025-07-01)

Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction
by: Cristina Dopazo, et al.
Published: (2018-01-01)

Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation
by: Zheng-Li Xu, et al.
Published: (2025-06-01)

WCN25-2708 ABSOLUTE LYMPHOCYTE COUNT AS SIMPLE BEDSIDE TOOL TO OPTIMISE ATLG INDUCTION DOSE IN INTERMEDIATE RISK KIDNEY TRANSPLANT RECIPIENTS
by: Akash Gupta, et al.
Published: (2025-02-01)

Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide
by: OV Pirogova, et al.
Published: (2016-10-01)

Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation
by: Neslihan Mandaci Ṣanli, et al.
Published: (2025-07-01)

Cumulative rabbit anti-human thymocyte globulin dose to recipient weight during the peri-operative period is an independent risk factor for early postoperative urinary tract infection after kidney transplantation
by: Shujuan Li, et al.
Published: (2024-12-01)

WCN25-2356 REAL WORLD EXPERIENCE OF HIF-PHI – DESIDUSTAT (OXEMIA®) IN DIALYSIS AND NON-DIALYSIS DEPENDENT CKD ANEMIA PATIENTS
by: Vijay Sinha, et al.
Published: (2025-02-01)

Cytotoxicity of Environmentally Relevant Concentrations of Aluminum in Murine Thymocytes and Lymphocytes
by: Jamal Kamalov, et al.
Published: (2011-01-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

WCN24-1131 OUTCOMES OF LIVE RELATED RENAL TRANSPLANT RECIPIENTS WITH THE USAGE OF ATLG VS BASILIXIMAB AS AN INDUCTION AGENT
by: Ruchir Dave, et al.
Published: (2024-04-01)

Dual in vivo T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report
by: Azadeh Kiumarsi, et al.
Published: (2025-01-01)

12-Month Outcomes of a Prospective Randomized Trial Investigating Effects of IVIG on Top of rATG Versus rATG Alone in Pre-Sensitized Kidney Transplant Recipients: The INHIBIT Study
by: Ondrej Viklicky, et al.
Published: (2025-05-01)

Different Roles of a Rat Cortical Thymic Epithelial Cell Line In Vitro on Thymocytes and Thymocyte Hybridoma Cells: Phagocytosis, Induction of Apoptosis, Nursing and Growth Promoting Activities
by: Dragana Vu&#269;evi&#263;, et al.
Published: (2002-01-01)

Low Serum Vitamin D Is Associated with Anti-Thyroid-Globulin Antibody in Female Individuals
by: Xinling Wang, et al.
Published: (2015-01-01)

Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)
by: T. I. Smolyanova, et al.
Published: (2022-05-01)

Has-miR-30c-1-3p inhibits macrophage autophagy and promotes Mycobacterium tuberculosis survival by targeting ATG4B and ATG9B
by: Xianglin Peng, et al.
Published: (2025-03-01)

Protective anti‐prion antibodies in human immunoglobulin repertoires
by: Assunta Senatore, et al.
Published: (2020-08-01)

Development of Type 1 Diabetes Mellitus in Nonobese Diabetic Mice Follows Changes in Thymocyte and Peripheral T Lymphocyte Transcriptional Activity
by: Thais A. Fornari, et al.
Published: (2011-01-01)

INDUCTION OF IL-8 PRODUCTION BY THE METAL COMPLEXES OF γ-GLOBULIN FORMED WITH ZINC IONS
by: M. A. Apresova, et al.
Published: (2014-07-01)

Human anti-D immunoglobulin preparations: potency standardisation milestones
by: N. S. Vildanova, et al.
Published: (2022-10-01)

Determination of quality criteria for candidate standard for anti-D immunoglobulin
by: E. N. Kalinina, et al.
Published: (2024-01-01)

Four microcolumn agglutination anti-human globulin cards in unexpected antibody screening results: a comparative analysis
by: SONG Ke, et al.
Published: (2024-12-01)

The Effectiveness of Anti-R. equi Hyperimmune Plasma against R. equi Challenge in Thoroughbred Arabian Foals of Mares Vaccinated with R. equi Vaccine
by: Osman Erganis, et al.
Published: (2014-01-01)

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)

Anti-aging Effect of Camel Milk Immunoglobulin G on Caenorhabditis elegans
by: ZHAO Xiaomeng, GONG Chunmiao, CHEN Shuxing, WANG Xiaonan, LI Qianwen
Published: (2024-11-01)

Ghrelin improves small intestinal barrier damage in sepsis by promoting miR-143/ATG2B-mediated autophagy
by: Jingquan Liu, et al.
Published: (2025-01-01)

Ghrelin improves small intestinal barrier damage in sepsis by promoting miR-143/ATG2B-mediated autophagy.
by: Jingquan Liu, et al.
Published: (2025-01-01)

Structure of the WIPI3/ATG16L1 Complex Reveals the Molecular Basis for the Recruitment of the ATG12~ATG5-ATG16L1 Complex by WIPI3
by: Xinyu Gong, et al.
Published: (2024-12-01)

Anti-diabetes activity of (R)-gentiandiol in KKAy type 2 mice
by: Yaqi Xu, et al.
Published: (2025-05-01)